Researchers demonstrated that ABCC4 is essential to signalling in the SHH subgroup of medulloblastomas and when expression was reduced in mice, the tumours shrank.
List view / Grid view
Scientists have produced hundreds of organoids which they say could be produced on a large-scale as a low-cost tissue model to help research and test new medulloblastoma therapies.
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
Researchers raise hopes for developing a combination targeted therapy to treat medulloblastoma and other tumours...
St. Jude Children’s Research Hospital discovery of a regulatory enzyme working at the primary cilium could lead to treatments for the brain tumour medulloblastoma.